With this event you will get the best advices on how to implement new GVP updates into the real world settings, how to select fit-for-purpose response strategies to growing Health Authority requests and generally, how to improve the pharmacovigilance and risk management procedures in your company. Besides, you will hear many interesting and immersive case studies on topics such as Post-Authorization Safety Studies, RMPs, Patient Support Programs, signal detection, benefit-risk assessment, globalization of pharmacovigilance, Medical Literature Monitoring, inspections preparations, digital listening and many more.

You will also find many networking and discussing opportunities there, where you will be able to exchange practical insights with other participants and pharmacovigilance/risk management experts. Save the date from 16th to 17th February and you won’t miss any news from the pharmacovigilance world in Berlin, 2017.

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Berlin!

Key Practical Learning Points of the Summit:

• Updates on GVP modules
• How to maintain a PV system globally?
• Post-Authorisation Safety Studies - a compliance nightmare?
• Benefit-Risk Management in the post-marketing setting
• Medical Literature Monitoring and EMA implication
• Pharmacovigilance Inspections Preparations
• Change management and pharmacovigilance
• New responsibilities in the signal management process

Who should attend? 

This event is designed for Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, QPPVs and Heads of departments from pharmaceutical industry involved in:

• Pharmacovigilance
• Drug Safety
• Safety & Risk Management
• Signal Detection
• Benefit-Risk Assessment
• Safety Evaluation
• Regulatory Affairs, Pharmacovigilance
• PV Governance
• Safety Surveillance
• Pharmacovigilance Operations
• PV Inspection and Audit Readiness
• Patient Support Programs
• Market Research Programs
• Clinical SafetyMedical Safety
• Medical Information
• Pharmacoepidemiology
• Case Management